Monitoring Toxicity, Impact, and Adherence of Hydroxyurea in Children with Sickle Cell Disease

Por Brandow, Amanda M., Panepinto, Julie A.
Publicado em 2011

Hydroxyurea Use in Sickle Cell Disease: The Battle with Low Rates of Prescription, Poor Patient Compliance, and Fears of Toxicities and Side Effects

Por Brandow, Amanda M., Panepinto, Julie A.
Publicado em 2010

Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients with Sickle Cell Disease

Por Brandow, Amanda M., Panepinto, Julie A.
Publicado no J Pediatr Hematol Oncol (2016)

Development of the PedsQL™ sickle cell disease module items: qualitative methods

Por Panepinto, Julie A., Torres, Sylvia, Varni, James W.
Publicado em 2011

DIFFERENCES IN HEALTH RELATED QUALITY OF LIFE IN CHILDREN WITH SICKLE CELL DISEASE RECEIVING HYDROXYUREA

Por Thornburg, Courtney D., Calatroni, Agustin, Panepinto, Julie A.
Publicado em 2011

A psychometric evaluation of the PedsQL™ Family Impact Module in parents of children with sickle cell disease

Por Panepinto, Julie A, Hoffmann, Raymond G, Pajewski, Nicholas M
Publicado em 2009

Hydroxyurea in Children with Sickle Cell Disease: Practice Patterns and Barriers to Utilization

Por Brandow, Amanda M., Jirovec, Danielle L., Panepinto, Julie A.
Publicado em 2010

The Impact of a Multidisciplinary Pain Management Model on Sickle Cell Disease Pain Hospitalizations

Por Brandow, Amanda M., Weisman, Steven J., Panepinto, Julie A.
Publicado em 2010

Post-discharge Pain, Functional Limitations, and Impact on Caregivers of Children with Sickle Cell Disease Treated for Painful Events

Por Brandow, Amanda M., Brousseau, David C., Panepinto, Julie A.
Publicado em 2008

The Effect of Parental Mental Health on Proxy reports of Health-related Quality of Life in Children with Sickle Cell Disease

Por Panepinto, Julie A., Hoffmann, Raymond G., Pajewski, Nicholas M.
Publicado em 2010

Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease

Por Beverung, Lauren M., Varni, James W., Panepinto, Julie A.
Publicado no J Pediatr Hematol Oncol (2015)

Neuropathic Pain in Patients with Sickle Cell Disease

Por Brandow, Amanda M., Farley, Rebecca A., Panepinto, Julie A.
Publicado no Pediatr Blood Cancer (2013)

Early Insights into the Neurobiology of Pain in Sickle Cell Disease: A Systematic Review of the Literature

Por Brandow, Amanda M., Farley, Rebecca A., Panepinto, Julie A.
Publicado no Pediatr Blood Cancer (2015)

The Performance of the PedsQL™ Generic Core Scales in Children with Sickle Cell Disease

Por Panepinto, Julie A., Pajewski, Nicholas M., Foerster, Lisa M., Hoffmann, Raymond G.
Publicado em 2008

Vaso-occlusive Painful Events in Sickle Cell Disease: Impact on Child Well-Being

Por Brandow, Amanda M., Brousseau, David C., Pajewski, Nicholas M., Panepinto, Julie A.
Publicado em 2010

Severe Thrombocytopenia in a Child Secondary to Passive Platelet Antibody Transfer from a Plasma Transfusion

Por Collins, Chelsea L., Scott, J. Paul, Panepinto, Julie A., Punzalan, Rowena C.
Publicado no J Pediatr Hematol Oncol (2013)

Ambulatory Quality Indicators to Prevent Infection in Sickle Cell Disease

Por Beverung, Lauren M., Brousseau, David, Hoffmann, Raymond G., Yan, Ke, Panepinto, Julie A.
Publicado no Am J Hematol (2014)

Impact of family income and sickle cell disease on the health-related quality of life of children

Por Panepinto, Julie A., Pajewski, Nicholas M., Foerster, Lisa M., Sabnis, Svapna, Hoffmann, Raymond G.
Publicado em 2008

The Use of Neuropathic Pain Drugs in Children with Sickle Cell Disease is Associated with Older Age, Female Gender and Longer Length of Hospital Stay

Por Brandow, Amanda M., Farley, Rebecca A., Dasgupta, Mahua, Hoffmann, Raymond G., Panepinto, Julie A.
Publicado no J Pediatr Hematol Oncol (2015)

The Effect of CYP2D6 polymorphisms on the Response to Pain Treatment for Pediatric Sickle Cell Pain Crisis

Por Brousseau, David C, McCarver, D Gail, Drendel, Amy L, Divakaran, Karthika, Panepinto, Julie A
Publicado em 2007